People · Operator
Named in public records as an officer, director or promoter · active 2011–2021 · Other, Other Health Care, Manufacturing
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Myoscience, Inc | — | Other | Series B | $122.6M | $83.1M | 2018 |
| Neuronetics, Inc. | — | Other Health Care | Series B | $118.7M | $332.3M | 2011 |
| Dfine Inc | — | Other | Series B | $77.3M | $290.6M | 2013 |
| Cardionomic, Inc. | — | Other Health Care | Series B | $51.7M | $76.2M | 2021 |
| SPRiZZi Bev-Co., Inc | — | Manufacturing | Series A | $5.0M | $49.9M | 2018 |
Brian Farley at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Brian Farley on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert Anderson | 1 | 24 |
| Ali Behbahani | 1 | 17 |
| Richard Ferrari | 1 | 15 |
| Robert Grant | 1 | 12 |
| Tara Butler | 1 | 12 |
| Jonathan Silverstein | 1 | 10 |
| Russell Hirsch | 1 | 10 |
| P. Sherrill Neff | 1 | 8 |
| Csaba Truckai | 1 | 7 |
| Kevin Mosher | 1 | 6 |
| Anthony Lando | 1 | 6 |
| David Clapper | 1 | 6 |
| Richard M. Ferrari | 1 | 5 |
| J. Casey McGlynn | 1 | 5 |
| Clint Carnell | 1 | 4 |
| Ron Hunt | 1 | 4 |
| DAN SACHS | 1 | 4 |
| Wilfred Jaeger | 1 | 4 |
| Michael DeMane | 1 | 4 |
| Cary . Vance | 1 | 4 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.